|
Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia |
University of Rochester |
Cure4Cam Childhood Cancer Foundation |
|
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine |
I Care I Cure |
|
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia |
Bear Necessities Pediatric Cancer Foundation |
|
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University |
Izzy’s Infantry |
|
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University |
Izzy’s Infantry |
|
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego |
Northwestern Mutual Foundation |
|
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan |
Northwestern Mutual Foundation |
